Dr Peter McCullough, Harvey Risch and George Fareed: Early Treatment of Coronavirus and Hydroxychloroquine

There is a deadly idea abroad the land — oft and tragically repeated by mainstream and big tech media — that there is no early treatment for COVID-19.

Accordingly, hundreds of thousands who have fallen ill have been advised to wait at home without help until their hospitalizations and ensuing deaths.

In Western nations, doctors who dare to speak out or to prescribe early Covid-19 treatments (based on clinical trials that the media have failed to report) have been openly censured and ridiculed.

For example, three top-of-their-field, award-winning physicians who testified at a US Senate Hearing in November 2020 were attacked as “snake-oil salesmen” in a bizarre New York Times opinion piece.

That was how Dr. Ashish Jha, health policy professor at Brown University, described Yale epidemiologist Dr. Harvey Risch (on the editorial board of the American Journal of Epidemiology for decades), Baylor’s Vice Chair of Medicine Dr. Peter McCullough, and California’s “rural physician of the year,” Dr. George Fareed.

Drs. George Fareed, Peter McCullough, and Harvey Risch


None of these men have conflicts of interest with the pharmaceutical industry. The NYT did not mention that this is not true of Dr. Jha, who regularly advocates for vaccines in the media, who has never treated a Covid patient, and who has less impressive academic qualifications than Risch or McCullough. (See Jha’s comparative citation rating in Google Scholar.)

It is common knowledge that scientists such as Galileo and Einstein were attacked by the threatened establishments of their day, as were medical geniuses throughout history.

As deaths pile up, we cannot let the dark ages continue to dominate 2021.

The Tragically Censored Online Physician Resource

This review article explores a superbly designed, highly navigable website that has continuously updated the evidence-based research on early Covid-19 treatments since June 2020. The website is so exhaustively comprehensive that it could be considered a journal in itself, produced by a team of competent, committed editors.

While out in the open, some of these physicians and researchers were victimized by media attacks, de-certification, and firings from their jobs. Incredibly, some have even been banned from Twitter and Facebook for spreading “misinformation” — in the form of published peer-reviewed journals indexed by the world-leading US National Library of Medicine.

Although this singular resource has been developed and posted anonymously, one observer commented on Reddit, “It doesn’t really matter who built it, imo. All studies are referenced/linked.”

The Website Itself: The Home Page is at c19study.com

The studies for Covid’s readily-available, low-cost, and evidence-based early treatments are divided into sections: Ivermectin, Vitamin D, Hydroxychloroquine, Vitamin C, and Zinc.


To take HCQ as an example, a summary page of trial outcomes is initially displayed: (updated March 2/01)


Followed by an up-to-date graphic of global HCQ use: (updated Feb. 2/01)


Followed by many tables such as: (updated March 2/01)




A global list of hydroxychloroquine Covid-19 treatment studies and outcomes, divided into early treatment and late treatment results, and complete with links and abstracts, is available at https://hcqmeta.com/ The HCQ data alone can be downloaded as a 71-page pdf.

The project has kept up with the recent highly encouraging work on Vitamin D efficacy during hospitalization. Below is a sample of the kind of lists that are maintained for each of the treatments covered: 



Each of these articles can be opened to reveal a gold mine of further information: 

 


A final example can be taken from the extensive work on Ivermectin: 


For Ivermectin, as for the other early treatments, the editors offer an inclusion statement and an invitation to participate: 

“For search methods, inclusion criteria, effect extraction criteria (more serious outcomes have priority), PRISMA answers, and statistical methods see ivmmeta.com. In Vitro, Ex Vivo, Meta, Theory, Safety, Review, and News items are not included in the study count. There is a total of 85 items. Studies with preprints and journal versions are listed under the earlier preprint date. 

Please send us corrections, updates, or comments.” 

The all-important early home treatment algorithm for practising physicians to consult:

 

Shockingly, the Twitter account informing the world of all this painstaking research has been suspended: 

Comments

Labels

Show more

Archive

Show more

Popular posts from this blog

Top Oncologist Blows Whistle: ‘Ivermectin Proven More Effective Than Chemotherapy’

Ivermectin and Fenbendazole: Treating Turbo Cancer - Dr William Makis

Fenbendazole Joe Tippens Protocol: A Step-by-Step Guide (2024)

Fenbendazole for Humans: Safety and Efficacy Examined

FENBENDAZOLE in Stage 4 Cancers - the 2021 Stanford University Case Series

Fenbendazole: Questions Answered, Things to Know, Useful Tips - Ben Fen

12 Types of Zinc Supplementation and Absorption 2024

Fenbendazole Cancer Success Stories and Treatment Testimonials: Case Series Compilation (2024)

FENBENDAZOLE and CANCER - at least 12 Anti-Cancer Mechanisms of Action - Dr William Makis (2024)

I-PREVENT CANCER protocol: An Evidence-Based Guide to Cancer Prevention (2024 Edition)